European Journal of Obstetrics & Gynecology and Reproductive Biology 2001: Vol 94 Index

6 Pages·2001·1.6 MB·English

EUROPEAN JOURNAL OF
OBSTETRICS &
GYNECOLOGY
AND REPRODUCTIVE BIOLOGY
European Journal of Obstetrics & Gynecology and
Reproductive Biology 94 (2001) 320—322 www.elsevier.com/locate/ejogrb
Author index
Volume 94 (2001)
Al-Hasani, S., see El-Sheikh, M.M. 94, 245 Bukulmez, O., Yucel, A., Yarali, H., Bildirici, 1., Gurgan, T., The origin of
Ali Ahmed, S.-A., see Dechaud, H. 94, 97 spermatozoa does not affect intracytoplasmic sperm injection
Aligier, N., see Dechaud, H. 94, 97 outcome 94, 250
Arad, I., Baras, M., Gofin, R., Bar—Oz, B., Peleg, O., Does parity affect Bull, S.B., see Magee, L.A. 94, 205
the neonatal outcome of very-low-birth-weight infants? 94, 283 Buytaert, P., see Tjalma, W. 94, 270
Atanackovic, G., see Koren, G. 94, 31
Attard, C., see Koren, G. 94, 31 Cabrol, D., see Goffinet, F. 94, 59
Cassaing, S., see Bessieres, M.H. 94, 37
Banerjee, K., see Roy, K.K. 94, 307 Chanavaz, I., see Mantel, A. 94, 296
Banerjee, N., see Deka, D. 94, 152 Chandra, K., see Koren, G. 94, 31
Baras, M., see Arad, |. 94, 283 Cheung, T.H., see Chung, T.K.H. 94, 121
Bar—Oz, B., see Arad, |. 94, 283 Choudhary, V.P., see Deka, D. 94, 152
Bashiri, A., see Holcberg, G. 94, 230 Chung, T.K.H., Ip, T.Y., Hampton, G.M., Wang, V.W., Cheung, T.H.,
Batorfi, J., see Toth, A. 94, 46 Wong, Y.F., Microsatellite instability in cervical carcinoma 94, 121
Bauer, O., see El-Sheikh, M.M. 94, 245 Corbisier, C., see Faron, G. 94, 304
Beerendonk, C.C.M., Braat, D.D.M., Hop, W.C.J., Merkus, J.M.W.M., van Cosson, M., Rajabally, R., Querleu, D., Crepin, G., Long term complica-
Dop, P.A., Dynamics of immunoreactive endothelin plasma _ levels tions of vaginal hysterectomy: a case control study 94, 239
during ovarian stimulation for in vitro fertilization with and without Courjault, C., see Bessieres, M.H. 94, 37
dietary sodium restriction 94, 103 Cravello, L., see Bretelle, F. 94, 23
Berberich, W., Schnabel, K., Berg, D., Lamprecht, E., Boost irradiation of Crepin, G., see Cosson, M. 94, 239
breast carcinoma: teletherapy vs. brachytherapy 94, 276
Berg, D., see Berberich,W. 94, 276 Daskalakis, G.J., Mavrommatis, K.G., Moulopoulos, G.K., Diakomanolis,
Berrebi, A., see Bessieres, M.H. 94, 37 E.S., Michalas, S.S., Endometrial cancer in patients under 30 years of
Bessieres, M.H., Berrebi, A., Rolland, M., Bloom, M.C., Roques, C., age. A report of two cases 94, 149
Cassaing, S., Courjault, C., Séguéla, J.-P., Neonatal screening for Dechaud, H., Ali Ahmed, S.-A., Aligier, N., Vergnes, C., Hedon, B., Does
congenital toxoplasmosis in a cohort of 165 women infected during transvaginal hydrolaparoscopy render standard diagnostic laparoscopy
pregnancy and influence of in utero treatment on the results of neonatal obsolete for unexplained infertility investigation? 94, 97
tests 94, 37 de Groot, A.N.J.A., see Den Hertog, C.E.C. 94, 8
Bildirici, I., see Bukulmez, O. 94, 250 Deinum, H.T., see Van Lingen, R.A. 94, 73
Birnie, E., see Monincx, W.M. 94, 197 Deka, D., Banerjee, N., Roy, K.K., ChoudharyV.,P ., Kashyap, R., Takkar,
Bishai, R., see Koren, G. 94, 31 D., Aplastic anaemia during pregnancy: variable clinical course and
Blanc, B., see Bretelle, F. 94, 23 outcome 94, 152
Blaszkowska, I., see Polak, G. 94, 261 Deka, D., see Malhotra, N. 94, 301
Blauer, M., see Tinkanen, H. 94, 109 den Hertog, C.E.C., De Groot, A.N.J.A.V,a n Dongen, P.W.J., History and
Bleker, O.P., see Monincx, W.M. 94, 197 use of oxytocics 94, 8
Blondel, B., see Hemminki, E. 94, 145 D’ercole, C., see Bretelle, F. 94, 23
Bloom, M.C., see Bessieres, M.H. 94, 37 Descargues, G., see Mantel, A. 94, 296
Body, G., see Perrotin, F. 94, 309 de Vries, L.S., see Vermeulen, G.M. 94, 290
Boehringer, H., see Ecochard, R. 94, 92 Diakomanolis, E.S., see Daskalakis, G.J. 94, 149
Bogers, J., see Tjalma, W. 94, 270 Doszpod, J., see Toth, A. 94, 46
Bonsel, G.J., see Monincx, W.M. 94, 197 Doumerc, S., see Mock, P. 94, 155
Braaksma, M.A., Renal and cerebral responses to hypoxemia in the ovine
fetus 94, 186 Ecochard, R., Marret, H., Rabilloud, M., Boehringer, H., Mathieu, C.,
Braat, D.D.M., see Beerendonk, C.C.M. 94, 103 Guerin, J.-F., Gonadotropin level abnormalities in women with cyclic
Brand, R., see Elferink-Stinkens, P.M. 94, 125 mastalgia 94, 92
Bretelle, F., Cravello, L., Shojai, R., Roger, V., D’ercole, C., Blanc, B., Ecochard, R., see Rabilloud, M. 94, 139
Vaginal birth following two previous cesarean sections 94, 23 Egyed, J., see Toth, A. 94, 46
Brélmann, H.A.M., see Geomini, P.M.A.J. 94, 234 Elferink-Stinkens, P.M., Van Hemel, O.J.S., Brand, R., Merkus, J.M.W.M.,
Brown, J.E., see Sidebottom, A.C. 94, 216 The Perinatal Database of the Netherlands 94, 125
Bruinse. H.W., see Vermeulen, G.M. 94, 290 El-Sheikh, M.M., Hussein, M., Fouad, S., El-Sheikh, R., Bauer, O.,
PII: SO301-2115(00)00557-1
Author index vol. 94 (2001)
Al-Hasani, S., Limited ovarian stimulation (LOS), prevents the recur- Katz, M., see Holcberg, G. 94, 69
rence of severe forms of ovarian hyperstimulation syndrome in Katz, M., see Holcberg, G. 94, 230
polycystic ovarian disease 94, 245 Kenemans, P., see Nijman, H.W. 94, 114
El-Sheikh, R., see El-Sheikh, M.M. 94, 245 Kim, C.-R., see Yum, M.-K. 94, 51
Eskes, T., Specialist life 94, 160
Kjaergaard, N., Hein, M., Hyttel, L., Helmig, R.B., Sch@nheyder, H.C..,
Esteve, J., see Rabilloud, M. 94, 139
Uldbjerg, N., Madsen, H., Antibacterial properties of human amnion
and chorion in vitro 94, 224
Faron, G., Corbisier, C., Tecco, L., Vokaer, A., First sickle cell crisis
Kochar, S., see Malhotra, N. 94, 301
triggered by induction of labor in a primigravida 94, 304
Kohli, M., see Koren, G. 94, 31
Fernandez, H., see Lédée, N. 94, 189
Koren, G., Magee, L., Attard, C., Kohli, M., Atanackovic, G., Bishai, R.,
Fernandez, H., see Mock, P. 94, 155
Chandra, K., Navioz, Y., Maltepe, C., A novel method for the
Fernandez, H., see Voluménie, J.-L. 94, 79
evaluation of the severity of nausea and vomiting of pregnancy 94, 31
Fouad, S., see El-Sheikh, M.M. 94, 245
Koren, G., see Magee, L.A. 94, 205
Frydman, R., see Lédée, N. 94, 189
Kotarski, J., see Polak, G. 94, 261
Frydman, R., see Mock, P. 94, 155
Koziol-Montewka, M., see Polak, G. 94, 261
Frydman, R., see Voluménie, J.-L. 94, 79
Kremer, J.A.M., Fast Facts — Contraception 94, 159
Fulla, Y., see Goffinet, F. 94, 59
Kujansuu, E., see Tinkanen, H. 94, 109
Furman, B., see Holcberg, G. 94, 69
Kummer, A., see Nijman, H.W. 94, 114
Gati, 1, see Toth, A. 94, 46
Laippala, P., see Tinkanen, H. 94, 109
Geomini, P.M.A.J., Brélmann, H.A.M., Van Binsbergen, N.J.M., Mol,
Lamprecht, E., see Berberich, W. 94, 276
B.W., Vaginal vault suspension by abdominal sacral colpopexy for
Lansac, J., see Perrotin, F. 94, 309
prolapse: a follow up study of 40 patients 94, 234
Lebrun, L., see Voluménie, J.-L. 94, 79
Gerards, L.J., see Vermeulen, G.M. 94, 290
Goel, S., see Malhotra, N. 94, 301 Lédée, N., Ville, Y., Musset, D., Mercier, F., Frydman, R., Fernandez, H.,
Goffinet, F., Maillard, F., Fulla, Y., Cabrol, D., Biochemical markers Management in intractable obstetric haemorrhage: an audit study on 61
(without markers of infection) of the risk of preterm delivery. Implica- cases 94, 189
tions for clinical practice 94, 59 Lemoine, J.-P., see Mantel, A. 94, 296
Gofin, R., see Arad, I. 94, 283 Logan, A., see Magee, L.A. 94, 205
Gogacz, M., see Polak, G. 94, 261 Lyonnais, C., see Perrotin, F. 94, 309
Griffin, C., Cardiac problems in pregnancy 94, 158
Griffin, C., Fetal disorders — diagnosis and management 94, 315 Madsen, H., see Kjaergaard, N. 94, 224
Guerin, J.-F., see Ecochard, R. 94, 92 Magee, L., see Koren, G. 94, 31
Gurgan, T., see Bukulmez, O. 94, 250 Magee, L.A., Bull, S.B., Koren, G., Logan, A., The generalizability of
trial data; a comparison of B-blocker trial participants with a prospec-
Haddad, G., see Perrotin, F. 94, 309 tive cohort of women taking B-blockers in pregnancy 94, 205
Hajdu, K., see Toth, A. 94, 46 Maillard, F., see Goffinet, F. 94, 59
Hampton, G.M., see Chung, T.K.H. 94, 121 Malek, A., see Holcberg, G. 94, 230
Hedon, B., see Dechaud, H. 94, 97 Malhotra, N., Deka, D., Takkar, D., Kochar, S., Goel, S., Sharma, M.C.,
Hein, M., see Kjaergaard, N. 94, 224 Hydatiform mole with coexisting live fetus in dichorionic twin
Helmig, R.B., see Kjaergaard, N. 94, 224 gestation 94, 301
Hemminki, E., Blondel, B., Antenatal care in Europe: varying ways of Malhotra, N., see Roy, K.K. 94, 307
providing high-coverage services 94, 145 Maltepe, C., see Koren, G. 94, 31
Hilgers, J., see Nijman, H.W. 94, 114 Mantel, A., Lemoine, J.-P., Descargues, G., Chanavaz, I., Mitrofanoff, P.,
Holcberg, G., Huleihel, M., Sapir, O., Katz, M., Tsadkin, M., Furman, B., Bladder exstrophy: gynecological and obstetrical characteristics with
Mazor, M., Myatt, L., Increased production of tumor necrosis factor-a reference to three cases 94, 296
by IUGR human placentae 94, 69 Marret, H., see Ecochard, R. 94, 92
Holcberg, G., Sapir, O., Huleihel, M., Katz, M., Bashiri, A., Mazor, M., Mathieu, C., see Ecochard, R. 94, 92
Malek, A., Tsadkin, M., Schneider, H., Indomethacin activity in the Mavrommatis, K.G., see Daskalakis, G.J. 94, 149
fetal vasculature of normal and meconium exposed human Mazor, M., see Holcberg, G. 94, 69
placentae 94, 230 Mazor, M., see Holcberg, G. 94, 230
Hop, W.C.J., see Beerendonk, C.C.M. 94, 103 Meijer, C.J.L.M., see Nijman, H.W. 94, 114
Huleihel, M., see Holcberg, G. 94, 69 Melief, C.J.M., see Nijman, H.W. 94, 114
Huleihel, M., see Holcberg, G. 94, 230 Mercier, F., see Lédée, N. 94, 189
Hussein, M., see El-Sheikh, M.M. 94, 245 Merkus, J.M.W.M., see Beerendonk, C.C.M. 94, 103
Hwang, J.-H., see Yum, M.-K. 94, 51 Merkus, J.M.W.M., see Elferink-Stinkens, P.M. 94, 125
Hyittel, L., see Kjaergaard, N. 94, 224 Merkus, J.M.W.M., The management of the menopaus, the millennium
review 94, 315
Ip, T.Y., see Chung, T.K.H. 94, 121 Michalas, S.S., see Daskalakis, GJ. 94, 149
Mitrofanoff, P., see Mantel, A. 94, 296
Jacobs Jr., D.R., see Sidebottom, A.C. 94, 216 Mock, P., Olivennes, F., Doumerc, S., Frydman, R., Fernandez, H..,
Jézwik, M., see Jozwik, M. 94, 256 Simultaneous bilateral tubal pregnancy after intracytoplasmic sperm
Jozwik, M., see Jozwik, M. 94, 256 injection treated by conservative medical treatment. Interest of sonog-
J6ozwik, M., Jozwik, M., Wolezynski, S., Jozwik, M., Szamatowicz, M., raphic follow-up 94, 155
Ammonia concentration in human preovulatory ovarian follicles 94, Mol, B.W., see Geomini, P.M.A.J. 94, 234
256 Monincx, W.M., Birnie, E., Zondervan, H.A., Bleker, O.P., Bonsel, G.J.,
Maternal health, antenatal and at 8 weeks after delivery, in home
Kashyap, R., see Deka, D. 94, 152 versus in-hospital fetal monitoring in high-risk pregnancies 94, 197
Author index vol. 94 (2001)
Moulopoulos, G.K., see Daskalakis, G.J. 94, 149 Tecco, L., see Faron, G. 94, 304
Musset, D., see Lédée, N. 94, 189 Thornton, J., Specialist life 94, 317
Myatt, L., see Holcberg, G. 94, 69 Tibboel, D., see Van Lingen, R.A. 94, 73
Tinkanen, H., Blaéuer, M., Laippala, P., Tuohimaa, P., Kujansuu, E.,
Navioz, Y., see Koren, G. 94, 31 Correlation between serum inhibin B and other indicators of the
Nijman, H.W., van Diest, P.J., Poort-Keesom, R.J.J., von Mensdorff- ovarian function 94, 109
Pouilly, S., Verstraeten, R.A., Kummer, A., Meijer, C.J.L.M., Melief, Tjalma, W., Weyler, J., Pollefliet, C., Bogers, J., Van Marck, E., Van Dam,
C.J.M., Hilgers, J., Kenemans, P., T cell infiltration and MHC | and II P., Buytaert, P., The evaluation of proliferative activity in CIN III and
expression in the presence of tumor antigens: An immunohistochemical microinvasive cervical cancer and its role in recurrence 94, 270
study in patients with serous epithelial ovarian cancer 94, 114 Toth, A., Tardy, E.P., Hajdu, K., Batorfi, J., Doszpod, J., Egyed, J., Gati,
I., Fluorescence in situ hybridization of chorionic interphase cells for
Okken, A., see Van Lingen, R.A. 94, 73 prenatal screening of Down syndrome 94, 46
Olivennes, F., see Mock, P. 94, 155 Tsadkin, M., see Holcberg, G. 94, 69
Tsadkin, M., see Holcberg, G. 94, 230
Park, E.-Y., see Yum, M.-K. 94, 51 Tuohimaa, P., see Tinkanen, H. 94, 109
Paz, Y., Solt, L., Zimmer, E.Z., Variables associated with meconium
aspiration syndrome in labors with thick meconium 94, 27
Uldbjerg, N., see Kjaergaard, N. 94, 224
Peleg, O., see Arad, I. 94, 283
Perrotin, F., Sembely-Taveau, C., Haddad, G., Lyonnais, C., Lansac, J.,
van Binsbergen, N.J.M., see Geomini, P.M.A.J. 94, 234
Body, G., Prenatal diagnosis and early in utero management of fetal
van Dam, P., see Tjalma, W. 94, 270
dyshormonogenetic goiter 94, 309
van de Logt, F., see Van Lingen, R.A. 94, 73
Petros, P.P., Skilling, P.M., Pelvic floor rehabilitation in the female
van Diest, P.J., see Nijman, HW. 94, 114
according to the integral theory of female urinary incontinence. First
van Dongen, P-'W.J., see Den Hertog, C.E.C. 94, 8
report 94, 264
van Dop, P.A., see Beerendonk, C.C.M. 94, 103
Polak, G., Koziol-Montewka, M., Gogacz, M., Blaszkowska, I., Kotarski,
van Eyck, J., see Van Lingen, R.A. 94, 73
J., Total antioxidant status of peritoneal fluid in infertile women 94,
van Geelen, J.M., Clinical Urogynaecology 94, 158
261
Van Hemel, O.J.S., see Elferink-Stinkens, P.M. 94, 125
Pollefliet, C., see Tjalma, W. 94, 270
van Lingen, R.A., Quak, C.M.E., Deinum, H.T., van de Logt, F., Van
Poort-Keesom, R.J.J., see Nijman, HW. 94, 114
Eyck, J., Okken, A., Tibboel, D., Effects of rectally administered
paracetamol on infants delivered by vacuum extraction 94, 73
Quak, C.M.E., see Van Lingen, R.A. 94, 73
Van Marck, E., see Tjalma, W. 94, 270
Querleu, D., see Cosson, M. 94, 239
Vergnes, C., see Dechaud, H. 94, 97
Verhaar, M.C., Rabelink, T.J., The endothelium: a gynecological and
Rabelink, T.J., see Verhaar, M.C. 94, 180
obstetric point of view 94, 180
Rabilloud, M., see Ecochard, R. 94, 92
Vermeulen, G.M., Bruinse, H.W., Gerards, L.J., De Vries, L.S., Perinatal
Rabilloud, M., Ecochard, R., Estéve, J., Maternity hospitals ranking on
risk factors for cranial ultrasound abnormalities in neonates born after
prophylactic caesarean section rates: uncertainty associated with
spontaneous labour before 34 weeks 94, 290
ranks 94, 139
Rajabally, R., see Cosson, M. 94, 239 Verstraeten, R.A., see Nijman, H.W. 94, 114
Roger, V., see Bretelle, F. 94, 23 Vial, M., see Voluménie, J.-L. 94, 79
Rolland, M., see Bessieres, M.H. 94, 37 Ville, Y., see Lédée, N. 94, 189
Roques, C., see Bessiéres, M.H. 94, 37 Visser, W., see Withagen, M.I.J. 94, 211
Roy, K.K., see Deka, D. 94, 152 Vokaer, A., see Faron, G. 94, 304
Roy, K.K., Malhotra, N., Banerjee, K., Recurrent eclampsia in a woman Voluménie, J.-L., Fernandez, H., Vial, M., Lebrun, L., Frydman, R.,
with chronic pyelonephritis 94, 307 Neonatal group B streptococcal infection. Results of 33 months of
Rozenberg, S., Clinical evidence supporting the rationale for constant universal maternal screening and antibioprophylaxis 94, 79
oestrogen, intermittent progestogen hormone replacement therapy 94, von Mensdorff-Pouilly, S., see Nijman, H.W. 94, 114
86
Wallenburg, H.C.S., Prevention of pre-eclampsia: status and perspectives
Sapir, O., see Holcberg, G. 94, 69 2000 94, 13
Sapir, O., see Holcberg, G. 94, 230 Wallenburg, H.C.S., see Withagen, M.I.J. 94, 211
Sarasin, F.P., Decision analysis and its application in clinical Wang, V.W., see Chung, T.K.H. 94, 121
medicine 94, 172 Weyler, J., see Tjalma, W. 94, 270
Schnabel, K., see Berberich,W. 94, 276 Withagen, M.I.J., Visser, W., Wallenburg, H.C.S., Neonatal outcome of
Schneider, H., see Holcberg, G. 94, 230 temporizing treatment in early-onset preeclampsia 94, 211
Schgnheyder, H.C., see Kjaergaard, N. 94, 224 Wolczynski, S., see Jozwik, M. 94, 256
Séguéla, J.-P., see Bessiéres, M.H. 94, 37 Wong, Y.F., see Chung, T.K.H. 94, 121
Sembely-Taveau, C., see Perrotin, F. 94, 309
Sharma, M.C., see Malhotra, N. 94, 301 Yarali, H., see Bukulmez, O. 94, 250
Shojai, R., see Bretelle, F. 94, 23 Yucel, A., see Bukulmez, O. 94, 250
Sidebottom, A.C., Brown, J.E., Jacobs Jr., D.R., Pregnancy-related Yum, M.-K., Park, E.-Y., Kim, C.-R., Hwang, J.-H., Alterations in
changes in body fat 94, 216 irregular and fractal heart rate behavior in growth restricted
Skilling, P.M., see Petros, P.P. 94, 264 fetuses 94, 51
Solt, I., see Paz, Y. 94, 27
Szamatowicz, M., see J6zwik, M. 94, 256 Zimmer, E.Z., see Paz, Y. 94, 27
Zondervan, H.A., see Monincx, W.M. 94, 197
Takkar, D., see Deka, D. 94, 152
Takkar, D., see Malhotra, N. 94, 301
Tardy, E.P., see Toth, A. 94, 46
EUROPEAN JOURNAL OF
OBSTETRICS &
GYNECOLOGY
AND REPRODUCTIVE BIOLOGY
European Journal of Obstetrics & Gynecology and
Reproductive Biology 94 (2001) 323-324 www.elsevier.com/locate/ejogrb
Subject index
Volume 94 (2001)
Ammonia 94, 256 Ectopic pregnancy 94, 155
Anatomical classification 94, 264 Electrotherapy 94, 264
Angiographic selective embolisation 94, 189 Embryo transfer 94, 103
Angiotensin II 94, 69 Endometrial cancer 94, 149
Antenatal care 94, 145 Endometriosis 94, 97
Antral follicles 94, 109 Endothelial dysfunction 94, 180
Aplastic anaemia 94, 152 Endothelin 94, 103
Approximate entropy 94, 51 Endothelium 94, 180
Azoospermia 94, 250 Exercises 94, 264
Beta-receptor blocker 94, 205 Fetal goiter 94, 308
Bilateral hypogastric artery ligation ‘ Fetal growth restriction 94, 51
Biochemical markers 94, 59 Fetal heart rate 94, 27
Bladder exstrophy 94, 296 Fetal membranes 94, 224
Body fat 94, 216 Fetal therapy 94, 308
Body-mass-index (BMI) 94, 109 Fluorescence in situ hybridization
Boost irradiation 94, 276 Follicle 94, 103
Breast cancer 94, 276; 94, 92 Follicular fluid 94, 256
Breast-conserving therapy 94, 276 Fractal correlation 94, 51
Breastfeeding 94, 216 Fractionation 94, 276
FSH 94, 109
Caesarean section rate 94, 139
Calcium supplementation 94, 13 Generalizability 94, 205
Case studies 94, 239 Gibbs sampling 94, 139
Cerebral response 94, 186 Gonadotropins 94, 92
Cervical carcinoma 94, 12] Group B streptococcus 94, 79
Cervical intraepithelial neoplasia 94, 270
Cesarean section 94, 23 Health care systems 94, 145
Cholecystectomy 94, 239 Hemolytic streptococci group B94, 224
Chorionic villi 94, 46 Hormone replacement therapy 94, 86
Chronic pyelonephritis 94, 306 Human amnion and chorion 94, 224
Clinical pregnancy 94, 250 Human 94, 114
Comparative research 94, 145 Hydatiform mole 94, 301
Complications 94, 239 Hypothyroidism 94, 308
Congenital toxoplasmosis 94, 37 Hypoxemia 94, 186
Cord blood serology 94, 37 Hysterectomy 94, 189; 94, 234
Cosmetic outcome 94, 276
Cost-effectiveness analysis 94, 172 ICSI 94, 155
Credible interval 94, 139 IgM and IgA antibodies 94, 37
Cyclic mastalgia 94, 92 Immunology 94, 114
Cystic periventricular leucomalacia 94, 290 In vitro fertilization 94, 103
Inaugural symptoms 94, 304
Decision analysis 94, 172 Increased risk pregnancies 94, 125
Decision tree 94, 172 Indomethacin 94, 230
Detection of Toxoplasma gondii 94, 37 Infant gender 94, 216
Diagnosis 94, 149 Infant 94, 73
Dichorionic twins 94, 301 Infertility 94, 261
Dietary sodium restriction 94, 103 Inflammatory cytokines 94, 69
Down syndrome 94, 46 Inhibin B94, 109
Integral theory 94, 264
Early onset neonatal infectious disease 94, 290 Interstitial irradiation 94, 276
PII: SO301-2115(00)00558-3
324 Subject index vol. 94 (2001)
Intracytoplasmic sperm injection 94, 250 Pregnancy 94, 152; 94, 216; 94, 296; 94, 304
Intraventricular hemorrhage 94, 290 Prenatal care 94, 145
IUGR 94, 69 Prenatal diagnosis 94, 308
Prenatal screening 94, 46
Labor 94, 27 Preovulatory ovarian follicle 94,
Laparoscopy 94, 97 Preterm delivery 94, 59
League table 94, 139 Prevention 94, 13
Life expectancy 94, 172 Progestogen 94, 86
Limited ovarian stimulation (LOS) 94, 245
Live fetus 94, 301 Quality-adjusted life expectancy 94, 172
Low-dose aspirin 94, 13
Randomized controlled trials 94, 205
Maternity hospital 94, 139 Rank 94. 139
Meconium aspiration syndrome 94, 27 Recurrence 94, 270
Meconuium — 94, 230 Recurrent eclampsia 94, 306
Menopause § 94, 86 Reliability of data 94, 125
sta_analveci .
Meta-analy sagll 94, 205 7 Renal blood flow 94, 186
Microsatellite — 94, 121 Rhode’s Score system 94, 31
Mitotic index 94, 270 Risk factors 94, 149
, , Risks 94, 59
National registration system 94, 125
Na¢ useeaa at nd v/ omitiitinngg of F pre2g-Onn;a ncy° (NVP) 94, 331 Sacral colpopexy 94, 234
Neonatal diagnosis 94, 37 ;
sg Screening 94, 79
Neonatal morbidity 94, 211
Secondary care 94, 125
Neonatal mortality 94, 211
cel lieiae Oh tat Sickle cell disease 94, 304
owt Skinfold thickness 94, 216
Newborn 94, 73 ‘
Sonography 94, 155
Oestrogen 94, 86 :S pontaanneeoouuss preprtetee rm bii rth 944, 290
Organization 94, 145
Temporizing hemodynamic treatment 94, 211
Ovarian cancer 94, 114
Testicular spermatozoa 94, 250
Ovarian hormones 94, 92
Thick meconium 94, 27
Ovarian hyperstimulation syndrome 94, 103
Total antioxidant status 94, 261
Ovarian hyperstimulation 94, 245
Transvaginal hydrolaparoscopy 94, 97
Ovarian stimulation 94, 103
Treatment 94, 149
Ovine fetus 94, 186
Trial labour 94, 23
Pain 94 73 Tumor antigens 94, 114
Paracetamol 94. 73 Tumor necrosis factor 94, 69
Parity 94, 283 Two uterine scars 94, 23
PCNA 94, 270
PCOD 94, 245 Ultrasonography 94, 308
PCOS 94, 245 Ultrasound 94, 290
Parity 94, 216 Under-reporting of first-week mortality 94, 125
Pelvic floor rehabilition 94, 264 Unexpiained infertility 94, 97
Perinatal Database of the Netherlands 94, 125 Urinary diversion 94, 296
Peritoneal fluid 94, 261 Urine production rate 94, 186
Placental vasoconstrictive activity 94, 230
Placenta 94, 69 Vacuum extraction 94, 73
Post partum haemorrhage 94, 189 Vaginal cultures 94, 79
Postmenopausal cardiovascular disease 94, 180 Vaginal delivery 94, 23
Pre-eclampsia 94, 13 Vaginal hysterectomy 94, 239
Prediction 94, 59 Vaginal prolapse 94, 234
Preeclampsia 94, 180; 94, 211 Very-low-birth-weight 94, 283
Pregnancy complications 94, 205; 94, 296 Vitamin C and E supplementation 94, 13
Pregnancy-induced hypertensive disorders 94, 13